Can graft endothelial cells initiate a host anti-graft immune response?

[1]  S. Antony,et al.  Human ehrlichiosis in a liver transplant recipient. , 1995, Transplantation.

[2]  D. Herndon,et al.  Transplanted acellular allograft dermal matrix. Potential as a template for the reconstruction of viable dermis. , 1995, Transplantation.

[3]  J. Pober,et al.  CD40 on human endothelial cells: inducibility by cytokines and functional regulation of adhesion molecule expression. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[4]  R. Pardi,et al.  Contact-dependent endothelial class II HLA gene activation induced by NK cells is mediated by IFN-gamma-dependent and -independent mechanisms. , 1995, Journal of immunology.

[5]  Y. Gruel,et al.  Evidence of noninvolvement of swine MHC class II in the in vitro proliferative response of human lymphocytes to porcine endothelial cells. , 1995, Transplantation.

[6]  S. Ceman,et al.  DMA and DMB are the only genes in the class II region of the human MHC needed for class II-associated antigen processing. , 1995, Journal of immunology.

[7]  F. Luscinskas,et al.  P-selectin and vascular cell adhesion molecule 1 mediate rolling and arrest, respectively, of CD4+ T lymphocytes on tumor necrosis factor alpha-activated vascular endothelium under flow , 1995, The Journal of experimental medicine.

[8]  C. Savage,et al.  Human vascular endothelial cells process and present autoantigen to human T cell lines. , 1995, International immunology.

[9]  P. Libby,et al.  Human vascular smooth muscle cells poorly co-stimulate and actively inhibit allogeneic CD4+ T cell proliferation in vitro. , 1995, Journal of immunology.

[10]  M. Yacoub,et al.  Human endothelial stimulation of allogeneic T cells via a CTLA-4 independent pathway. , 1994, Transplant immunology.

[11]  J. Pober,et al.  Endothelial cell-induced resistance to cyclosporin A in human peripheral blood T cells requires contact-dependent interactions involving CD2 but not CD28. , 1994, Journal of immunology.

[12]  J. Pober,et al.  Human T-cell-mediated destruction of allogeneic dermal microvessels in a severe combined immunodeficient mouse. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[13]  C. Orosz,et al.  Alloantigenicity of human endothelial cells. III. Quantitated indirect presentation of endothelial alloantigens to human helper T lymphocytes. , 1994, Transplantation.

[14]  M. Vora,et al.  Antigen presentation by human dermal microvascular endothelial cells. Immunoregulatory effect of IFN-gamma and IL-10. , 1994, Journal of immunology.

[15]  M. Yacoub,et al.  ALLOPROLIFERATIVE RESPONSES OF PURIFIED CD4+ AND CD8+ T CELLS TO ENDOTHELIAL CELLS IN THE ABSENCE OF CONTAMINATING ACCESSORY CELLS , 1994, Transplantation.

[16]  H. Deeg,et al.  Secondary malignancies after marrow transplantation for leukemia or aplastic anemia. , 1994, Transplantation.

[17]  M. Sayegh,et al.  Mechanisms of T cell recognition of alloantigen. The role of peptides. , 1994, Transplantation.

[18]  B. Arp,et al.  HLA-DMA and -DMB genes are both required for MHC class II/peptide complex formation in antigen-presenting cells , 1994, Nature.

[19]  J. Pober,et al.  Porcine aortic endothelial cells activate human T cells: direct presentation of MHC antigens and costimulation by ligands for human CD2 and CD28. , 1994, Immunity.

[20]  C. Orosz,et al.  Alloantigenicity of human endothelial cells. IV. Derivation, characterization, and utilization of gonadal vein endothelia to control endothelial alloantigenicity during lymphocyte-endothelial interactions. , 1994, Transplantation.

[21]  M. Croft,et al.  Naive versus memory CD4 T cell response to antigen. Memory cells are less dependent on accessory cell costimulation and can respond to many antigen-presenting cell types including resting B cells. , 1994, Journal of immunology.

[22]  C. Janeway,et al.  Signals and signs for lymphocyte responses , 1994, Cell.

[23]  C. Orosz,et al.  ALLOANTIGENICITY OF HUMAN ENDOTHELIAL CELLS II. ANALYSIS OF INTERLEUKIN 2 PRODUCTION AND PROLIFERATION BY T CELLS AFTER CONTACT WITH ALLOGENEIC ENDOTHELiA , 1994, Transplantation.

[24]  D. Ruiter,et al.  The proliferative response of human T cells to allogeneic IFN-gamma-treated endothelial cells is mediated via both CD2/LFA-3 and LFA-1/ICAM-1 and -2 adhesion pathways. , 1993, Transplant immunology.

[25]  C. Savage,et al.  Synergistic interactions of CD4+ and CD8+ T cell subsets with human vascular endothelial cells in primary proliferative allogeneic responses. , 1993, International immunology.

[26]  C. Haisch,et al.  T CELL SUBSET RESPONSES TO ALLOGENEIC ENDOTHELIUM: PROLIFERATION OF CD8+ BUT NOT CD4+ LYMPHOCYTES , 1993, Transplantation.

[27]  M. Hart,et al.  Differential activation of Th1 and Th2 CD4+ cells by murine brain microvessel endothelial cells and smooth muscle/pericytes. , 1993, Journal of immunology.

[28]  J. Pober,et al.  HUMAN CD4+ T CELLS PROLIFERATE TO HLA‐DR+ ALLOGENEIC VASCULAR ENDOTHELIUM: IDENTIFICATION OF ACCESSORY INTERACTIONS , 1993, Transplantation.

[29]  B. Holzmann,et al.  Triggering of L-selectin (gp90MEL-14) induces homotypic lymphocyte adhesion by a mechanism independent of LFA-1. , 1993, International immunology.

[30]  P. Cresswell,et al.  Cytokines increase transporter in antigen processing-1 expression more rapidly than HLA class I expression in endothelial cells. , 1992, Journal of immunology.

[31]  R. Cotran,et al.  Expression of vascular cell adhesion molecule-1 in human renal allografts. , 1992, Journal of the American Society of Nephrology : JASN.

[32]  K. Kato,et al.  CD48 is a counter-receptor for mouse CD2 and is involved in T cell activation , 1992, The Journal of experimental medicine.

[33]  M. Yacoub,et al.  Antigenic heterogeneity of vascular endothelium. , 1992, The American journal of pathology.

[34]  C. Orosz,et al.  Alloantigenicity of human endothelial cells. 1. Frequency and phenotype of human T helper lymphocytes that can react to allogeneic endothelial cells. , 1992, Journal of immunology.

[35]  Y. Minami,et al.  Association of human lymph node homing receptor (Leu 8) with the TCR/CD3 complex. , 1992, Journal of immunology.

[36]  R. Pardi,et al.  Signal requirements for the generation of CD4+ and CD8+ T-cell responses to human allogeneic microvascular endothelium. , 1991, Circulation research.

[37]  F. Luscinskas,et al.  Leukocyte adhesion molecule-1 (LAM-1, L-selectin) interacts with an inducible endothelial cell ligand to support leukocyte adhesion. , 1991, Journal of immunology.

[38]  J. Pober,et al.  Endothelial cell lymphocyte function-associated antigen-3 and an unidentified ligand act in concert to provide costimulation to human peripheral blood CD4+ T cells. , 1991, Cellular immunology.

[39]  H. Grey,et al.  Analysis of T cell stimulation by superantigen plus major histocompatibility complex class II molecules or by CD3 monoclonal antibody: costimulation by purified adhesion ligands VCAM-1, ICAM-1, but not ELAM-1 , 1991, The Journal of experimental medicine.

[40]  M. Nagarkatti,et al.  T-cell-receptor-independent activation of cytolytic activity of cytotoxic T lymphocytes mediated through CD44 and gp90MEL-14. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[41]  G. Rice,et al.  Induced expression of endothelial-leukocyte adhesion molecules in human cardiac allografts. , 1991, Transplantation.

[42]  J. Pober,et al.  IFN-gamma enhances endothelial activation induced by tumor necrosis factor but not IL-1. , 1990, Journal of immunology.

[43]  J. Pober,et al.  Lymphocyte-mediated activation of cultured endothelial cells (EC). CD4+ T cells inhibit EC class II MHC expression despite secreting IFN-gamma and increasing EC class I MHC and intercellular adhesion molecule-1 expression. , 1990, Journal of immunology.

[44]  Timothy A. Springer,et al.  Adhesion receptors of the immune system , 1990, Nature.

[45]  M. Thornhill,et al.  IL-4 regulates endothelial cell activation by IL-1, tumor necrosis factor, or IFN-gamma. , 1990, Journal of immunology.

[46]  M. Hart,et al.  Antigen presentation by brain microvessel smooth muscle and endothelium , 1990, Journal of Neuroimmunology.

[47]  J. Pober,et al.  Endothelial cells augment T cell interleukin 2 production by a contact- dependent mechanism involving CD2/LFA-3 interaction , 1990, The Journal of experimental medicine.

[48]  R. Cotran,et al.  Tumor necrosis factor and interferon-gamma induce distinct patterns of endothelial activation and associated leukocyte accumulation in skin of Papio anubis. , 1989, The American journal of pathology.

[49]  W. Fiers,et al.  Three distinct classes of regulatory cytokines control endothelial cell MHC antigen expression. Interactions with immune gamma interferon differentiate the effects of tumor necrosis factor and lymphotoxin from those of leukocyte alpha and fibroblast beta interferons , 1988, The Journal of experimental medicine.

[50]  H. Schellekens,et al.  IMPACT OF CLASS II MAJOR HISTOCOMPATIBILITY COMPLEX ANTIGEN EXPRESSION ON THE IMMUNOGENIC POTENTIAL OF ISOLATED RAT VASCULAR ENDOTHELIAL CELLS , 1987, Transplantation.

[51]  W. Fiers,et al.  Activation of cultured human endothelial cells by recombinant lymphotoxin: comparison with tumor necrosis factor and interleukin 1 species. , 1987, Journal of immunology.

[52]  P. Lipsky,et al.  Dissection of defective antigen presentation by interferon-gamma-treated fibroblasts. , 1987, Journal of immunology.

[53]  W. Fiers,et al.  Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon. , 1986, Journal of immunology.

[54]  W. Fiers,et al.  Two distinct monokines, interleukin 1 and tumor necrosis factor, each independently induce biosynthesis and transient expression of the same antigen on the surface of cultured human vascular endothelial cells. , 1986, Journal of immunology.

[55]  P. Libby,et al.  Inducible expression of class II major histocompatibility complex antigens and the immunogenicity of vascular endothelium. , 1986, Transplantation.

[56]  P. Lipsky,et al.  Antigen presentation by interferon-gamma-treated endothelial cells and fibroblasts: differential ability to function as antigen-presenting cells despite comparable Ia expression. , 1985, Journal of immunology.

[57]  G. Groenewegen,et al.  Lymphokine dependence of in vivo expression of MHC class II antigens by endothelium , 1985, Nature.

[58]  W. Fiers,et al.  Human dermal fibroblasts present tetanus toxoid antigen to antigen-specific T cell clones. , 1985, The Journal of clinical investigation.

[59]  A. Krensky,et al.  Target specificity and cell surface structures involved in the human cytolytic T lymphocyte response to endothelial cells. , 1985, Journal of immunology.

[60]  J. Fabre,et al.  Massive induction of donor-type class I and class II major histocompatibility complex antigens in rejecting cardiac allografts in the rat , 1985, The Journal of experimental medicine.

[61]  R. Vetto,et al.  The mechanism of antigen presentation by endothelial cells. , 1984, Immunobiology.

[62]  W. Fiers,et al.  Immune interferon activates multiple class II major histocompatibility complex genes and the associated invariant chain gene in human endothelial cells and dermal fibroblasts. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[63]  P. Lipsky,et al.  Immunologic function of endothelial cells: guinea pig aortic endothelial cells support mitogen-induced T lymphocyte activation, but do not function as antigen-presenting cells. , 1984, Journal of immunology.

[64]  W. Fiers,et al.  Lymphocytes recognize human vascular endothelial and dermal fibroblast Ia antigens induced by recombinant immune interferon , 1983, Nature.

[65]  P. Stastny,et al.  Accessory cell function of human endothelial cells. I. A subpopulation of Ia positive cells is required for antigen presentation. , 1983, Journal of immunology.

[66]  E. Thorsby,et al.  THE HUMAN MIXED LYMPHOCYTE‐ENDOTHELIUM CULTURE INTERACTION , 1975, Transplantation.

[67]  R. Germain,et al.  The biochemistry and cell biology of antigen processing and presentation. , 1993, Annual review of immunology.

[68]  R. Miller,et al.  Vascular endothelial cells enhance T cell responses by markedly augmenting IL-2 concentrations. , 1989, Cellular immunology.

[69]  W. Fiers,et al.  Recombinant human tumor necrosis factor increases mRNA levels and surface expression of HLA-A,B antigens in vascular endothelial cells and dermal fibroblasts in vitro. , 1986, Proceedings of the National Academy of Sciences of the United States of America.